Clearstead Advisors, LLC Bioventus Inc. Transaction History
Clearstead Advisors, LLC
- $7.4 Billion
- Q3 2025
A detailed history of Clearstead Advisors, LLC transactions in Bioventus Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 59 shares of BVS stock, worth $433. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59
Previous 2
2850.0%
Holding current value
$433
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BVS
# of Institutions
145Shares Held
50.1MCall Options Held
42.5KPut Options Held
100K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$95.7 Million28.43% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$51 Million18.87% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.81MShares$42.7 Million1.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$21.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$17.4 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $453M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...